Send to

Choose Destination
Br J Rheumatol. 1995 Nov;34 Suppl 2:43-8.

Efficacy of methotrexate in rheumatoid arthritis.

Author information

Department of Rheumatology and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.


Methotrexate (MTX), an antifolate agent, has been used in the treatment of rheumatoid arthritis (RA) for over two decades. Open clinical studies and short-term, randomized, placebo-controlled studies demonstrate the efficacy of MTX in active RA. Long-term prospective studies, including two of over 7 yr duration, report a sustained response and a corticosteroid-sparing effect. Comparative studies demonstrate superior efficacy to auranofin, azathioprine and cyclosporin A. A highly favourable retention rate with the drug has been noted in large studies from academic and community-based practices. Radiographic studies suggest a slowing of radiographic progression with the compound. MTX has become an accepted and widely used treatment for active RA.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center